Literature DB >> 34728185

Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond.

James R Goldenring1, Jason C Mills2.   

Abstract

The mucosa of the body of the stomach (ie, the gastric corpus) uses 2 overlapping, depth-dependent mechanisms to respond to injury. Superficial injury heals via surface cells with histopathologic changes like foveolar hyperplasia. Deeper, usually chronic, injury/inflammation, most frequently induced by the carcinogenic bacteria Helicobacter pylori, elicits glandular histopathologic alterations, initially manifesting as pyloric (also known as pseudopyloric) metaplasia. In this pyloric metaplasia, corpus glands become antrum (pylorus)-like with loss of acid-secreting parietal cells (atrophic gastritis), expansion of foveolar cells, and reprogramming of digestive enzyme-secreting chief cells into deep antral gland-like mucous cells. After acute parietal cell loss, chief cells can reprogram through an orderly stepwise progression (paligenosis) initiated by interleukin-13-secreting innate lymphoid cells (ILC2s). First, massive lysosomal activation helps mitigate reactive oxygen species and remove damaged organelles. Second, mucus and wound-healing proteins (eg, TFF2) and other transcriptional alterations are induced, at which point the reprogrammed chief cells are recognized as mucus-secreting spasmolytic polypeptide-expressing metaplasia cells. In chronic severe injury, glands with pyloric metaplasia can harbor both actively proliferating spasmolytic polypeptide-expressing metaplasia cells and eventually intestine-like cells. Gastric glands with such lineage confusion (mixed incomplete intestinal metaplasia and proliferative spasmolytic polypeptide-expressing metaplasia) may be at particular risk for progression to dysplasia and cancer. A pyloric-like pattern of metaplasia after injury also occurs in other gastrointestinal organs including esophagus, pancreas, and intestines, and the paligenosis program itself seems broadly conserved across tissues and species. Here we discuss aspects of metaplasia in stomach, incorporating data derived from animal models and work on human cells and tissues in correlation with diagnostic and clinical implications.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34728185      PMCID: PMC8792220          DOI: 10.1053/j.gastro.2021.10.036

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  138 in total

1.  CD44 variant isoform 9 emerges in response to injury and contributes to the regeneration of the gastric epithelium.

Authors:  Nina Bertaux-Skeirik; Mark Wunderlich; Emma Teal; Jayati Chakrabarti; Jacek Biesiada; Maxime Mahe; Nambirajan Sundaram; Joel Gabre; Jennifer Hawkins; Gao Jian; Amy C Engevik; Li Yang; Jiang Wang; James R Goldenring; Joseph E Qualls; Mario Medvedovic; Michael A Helmrath; Tayyab Diwan; James C Mulloy; Yana Zavros
Journal:  J Pathol       Date:  2017-08       Impact factor: 7.996

2.  Atrophic gastritis in young children and adolescents.

Authors:  O Ricuarte; O Gutierrez; H Cardona; J G Kim; D Y Graham; H M T El-Zimaity
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 3.  Chronic gastritis. A critical study of the progressive atrophy of the gastric mucosa.

Authors:  R Lambert
Journal:  Digestion       Date:  1972       Impact factor: 3.216

4.  Residual embryonic cells as precursors of a Barrett's-like metaplasia.

Authors:  Xia Wang; Hong Ouyang; Yusuke Yamamoto; Pooja Ashok Kumar; Tay Seok Wei; Rania Dagher; Matthew Vincent; Xin Lu; Andrew M Bellizzi; Khek Yu Ho; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Cell       Date:  2011-06-24       Impact factor: 41.582

5.  Gastric cancer originating from bone marrow-derived cells.

Authors:  Jeanmarie Houghton; Calin Stoicov; Sachiyo Nomura; Arlin B Rogers; Jane Carlson; Hanchen Li; Xun Cai; James G Fox; James R Goldenring; Timothy C Wang
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

6.  Patterns of gastric atrophy in intestinal type gastric carcinoma.

Authors:  Hala M T El-Zimaity; Hiroyoshi Ota; David Y Graham; Taiji Akamatsu; Tsutomu Katsuyama
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

7.  Proliferation and Differentiation of Gastric Mucous Neck and Chief Cells During Homeostasis and Injury-induced Metaplasia.

Authors:  Joseph Burclaff; Spencer G Willet; José B Sáenz; Jason C Mills
Journal:  Gastroenterology       Date:  2019-10-05       Impact factor: 22.682

8.  The clonal origins of dysplasia from intestinal metaplasia in the human stomach.

Authors:  Lydia Gutierrez-Gonzalez; Trevor A Graham; Manuel Rodriguez-Justo; Simon J Leedham; Marco R Novelli; Laura J Gay; Tania Ventayol-Garcia; Alicia Green; Ian Mitchell; David L Stoker; Sean L Preston; Shigeki Bamba; Eiji Yamada; Yuuki Kishi; Rebecca Harrison; Janusz A Jankowski; Nicholas A Wright; Stuart A C McDonald
Journal:  Gastroenterology       Date:  2011-01-09       Impact factor: 22.682

9.  Active Kras Expression in Gastric Isthmal Progenitor Cells Induces Foveolar Hyperplasia but Not Metaplasia.

Authors:  Eunyoung Choi; Anna L Means; Robert J Coffey; James R Goldenring
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-09-18

10.  Up-regulation of Aquaporin 5 Defines Spasmolytic Polypeptide-Expressing Metaplasia and Progression to Incomplete Intestinal Metaplasia.

Authors:  Su-Hyung Lee; Bogun Jang; Jimin Min; Ela W Contreras-Panta; Kimberly S Presentation; Alberto G Delgado; M Blanca Piazuelo; Eunyoung Choi; James R Goldenring
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2021-08-26
View more
  6 in total

Review 1.  The immune microenvironment in gastric adenocarcinoma.

Authors:  Yana Zavros; Juanita L Merchant
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-14       Impact factor: 73.082

2.  Differential pre-malignant programs and microenvironment chart distinct paths to malignancy in human colorectal polyps.

Authors:  Bob Chen; Cherie' R Scurrah; Eliot T McKinley; Alan J Simmons; Marisol A Ramirez-Solano; Xiangzhu Zhu; Nicholas O Markham; Cody N Heiser; Paige N Vega; Andrea Rolong; Hyeyon Kim; Quanhu Sheng; Julia L Drewes; Yuan Zhou; Austin N Southard-Smith; Yanwen Xu; James Ro; Angela L Jones; Frank Revetta; Lynne D Berry; Hiroaki Niitsu; Mirazul Islam; Karin Pelka; Matan Hofree; Jonathan H Chen; Siranush Sarkizova; Kimmie Ng; Marios Giannakis; Genevieve M Boland; Andrew J Aguirre; Ana C Anderson; Orit Rozenblatt-Rosen; Aviv Regev; Nir Hacohen; Kenta Kawasaki; Toshiro Sato; Jeremy A Goettel; William M Grady; Wei Zheng; M Kay Washington; Qiuyin Cai; Cynthia L Sears; James R Goldenring; Jeffrey L Franklin; Timothy Su; Won Jae Huh; Simon Vandekar; Joseph T Roland; Qi Liu; Robert J Coffey; Martha J Shrubsole; Ken S Lau
Journal:  Cell       Date:  2021-12-14       Impact factor: 66.850

Review 3.  Self-Renewal and Cancers of the Gastric Epithelium: An Update and the Role of the Lectin TFF1 as an Antral Tumor Suppressor.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

4.  Spliceosome inhibitor induces human hematopoietic progenitor cell reprogramming toward stemness.

Authors:  Liaoliao Dong; Chuijin Wei; Shumin Xiong; Ping Yu; Ren Zhou; Lin Cheng
Journal:  Exp Hematol Oncol       Date:  2022-06-10

5.  Regulation of the double-stranded RNA response through ADAR1 licenses metaplastic reprogramming in gastric epithelium.

Authors:  José B Sáenz; Nancy Vargas; Charles J Cho; Jason C Mills
Journal:  JCI Insight       Date:  2022-02-08

6.  Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota.

Authors:  Duochen Jin; Keting Huang; Miao Xu; Hongjin Hua; Feng Ye; Jin Yan; Guoxin Zhang; Yun Wang
Journal:  Gut Microbes       Date:  2022 Jan-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.